A BioJam, following the legislation for In Vitro Diagnostic Medical Devices, has already notified the National Authority of Medicines and Health Products, I.P. (Infarmed) about the distribution of NADAL COVID-19 Ag rapid antigen tests, an antigen rapid test that allows detection from the first 24 hours of contagion with results in just 15 minutes.<\/p>\n\n\n
This test allows detection from the first 24 hours of contagion, a virus protein that allows determining the infection, thus filling a gap in rapid diagnosis in the initial phase of infection, as this test has a detection window similar to PCR tests.<\/p>\n\n\n
Test results are obtained in just 15 minutes, without the need for instrumentation, significantly reducing false positives generated by contamination from other tests.<\/p>\n\n\n
The tests are manufactured in Germany and provide essential information at the time of the infection period when there is a higher risk of disease transmission.<\/p>\n\n\n
It is done with a simple device that detects the presence of a substance in a liquid sample without the need for specialized and expensive equipment.<\/p>\n\n\n
News published on www.netfarma.pt<\/a><\/p>\n\n\n